2025 annual financial data
Novavax 2025 Operating margin
Direct answer
Operating margin was 50.14%.
Operating income was 563,271,000 USD and net income was 440,302,000 USD.
Operating cash flow was -244,635,000 USD.
Get free Novavax email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,123,479,000 USD
- Operating income
- 563,271,000 USD
- Net income
- 440,302,000 USD
- Operating cash flow
- -244,635,000 USD